Simplex Trading
ABBV icon

Simplex Trading’s AbbVie ABBV Stock Holding History

Simplex Trading’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.3M Sell
116,300
-133,400
-53% -$29.6M 0.02% 362
2025
Q4 		$57.1M Sell
249,700
-58,100
-19% -$13.2M 0.03% 252
2025
Q3 		$71.3M Buy
307,800
+29,300
+11% +$5.97M 0.04% 263
2025
Q2 		$51.7M Sell
278,500
-164,400
-37% -$30.6M 0.03% 285
2025
Q1 		$92.8M Sell
442,900
-76,700
-15% -$14.9M 0.06% 152
2024
Q4 		$92.3M Buy
519,600
+10,700
+2% +$1.97M 0.05% 178
2024
Q3 		$100M Buy
508,900
+191,800
+60% +$35.8M 0.06% 159
2024
Q2 		$54.4M Sell
317,100
-39,200
-11% -$6.49M 0.03% 287
2024
Q1 		$64.9M Buy
356,300
+23,100
+7% +$3.98M 0.04% 275
2023
Q4 		$51.6M Sell
333,200
-100,300
-23% -$14.6M 0.03% 331
2023
Q3 		$64.6M Sell
433,500
-159,500
-27% -$23.4M 0.05% 221
2023
Q2 		$79.9M Buy
593,000
+18,600
+3% +$2.73M 0.07% 184
2023
Q1 		$91.5M Sell
574,400
-407,000
-41% -$62.2M 0.08% 170
2022
Q4 		$159M Buy
981,400
+579,100
+144% +$88.8M 0.17% 76
2022
Q3 		$54M Sell
402,300
-146,500
-27% -$21M 0.06% 233
2022
Q2 		$84.1M Sell
548,800
-133,900
-20% -$20.5M 0.09% 144
2022
Q1 		$111M Sell
682,700
-33,200
-5% -$4.82M 0.1% 135
2021
Q4 		$96.9M Sell
715,900
-86,200
-11% -$10.2M 0.1% 154
2021
Q3 		$91.6M Buy
802,100
+3,800
+0.5% +$434K 0.09% 162
2021
Q2 		$89.9M Buy
798,300
+794,682
+21,965% +$89.5M 0.09% 161
2021
Q1 		$39.2M Sell
3,618
-2,854
-44% -$305K 0.07% 163
2020
Q4 		$69.3M Buy
6,472
+2,466
+62% +$237K 0.09% 127
2020
Q3 		$35.1M Sell
4,006
-106
-3% -$9.98K 0.05% 219
2020
Q2 		$40.4M Sell
4,112
-1,162
-22% -$102K 0.06% 167
2020
Q1 		$40.2M Sell
5,274
-2,895
-35% -$247K 0.07% 145
2019
Q4 		$72.3M Buy
8,169
+3,777
+86% +$314K 0.16% 71
2019
Q3 		$33.3M Sell
4,392
-1,985
-31% -$136K 0.09% 143
2019
Q2 		$46.4M Buy
6,377
+2,706
+74% +$213K 0.13% 90
2019
Q1 		$29.6M Buy
3,671
+1,499
+69% +$123K 0.08% 151
2018
Q4 		$20M Sell
2,172
-1,159
-35% -$102K 0.06% 204
2018
Q3 		$31.5M Sell
3,331
-201
-6% -$19.1K 0.1% 138
2018
Q2 		$32.7M Buy
3,532
+7
+0.2% +$684 0.13% 113
2018
Q1 		$1.93M Sell
3,525
-562
-14% -$61.7K 0.09% 195
2017
Q4 		$555K Buy
4,087
+1,702
+71% +$160K 0.02% 665
2017
Q3 		$152K Sell
2,385
-924
-28% -$70.3K 0.01% 1384
2017
Q2 		$423K Buy
3,309
+1,078
+48% +$72.5K 0.02% 741
2017
Q1 		$360K Buy
2,231
+518
+30% +$32.6K 0.02% 861
2016
Q4 		$521K Sell
1,713
-443
-21% -$27K 0.03% 524
2016
Q3 		$464K Buy
2,156
+95
+5% +$6.15K 0.03% 546
2016
Q2 		$332K Buy
2,061
+608
+42% +$37K 0.02% 724
2016
Q1 		$288K Buy
1,453
+111
+8% +$6.19K 0.02% 679
2015
Q4 		$320K Sell
1,342
-443
-25% -$25.5K 0.03% 610
2015
Q3 		$1.15M Sell
1,785
-1,164
-39% -$75.8K 0.08% 211
2015
Q2 		$400K Buy
2,949
+1,077
+58% +$70.3K 0.03% 470
2015
Q1 		$502K Buy
1,872
+275
+17% +$16.6K 0.06% 330
2014
Q4 		$233K Buy
+1,597
New +$101K 0.03% 534

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Simplex Trading's ABBV Position: Q1 2026 in Review

Simplex Trading sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 8,076 shares — an estimated $1.79M sold.

Simplex Trading first reported a position in ABBV in Q1 2015 and held it in 25 quarters. The position peaked at $24.6M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Simplex Trading reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 8,076 AbbVie shares in Q1 2026, an estimated $1.79M.
  • Simplex Trading first reported a position in AbbVie in Q1 2015 and held it in 25 quarters.
  • Simplex Trading's AbbVie position peaked at $24.6M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.